Inflammatory Markers and Risk of Heart Failure in Elderly Subjects Without Prior Myocardial Infarction: The Framingham Heart Study

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Circulation

• Publication date

  2003-03-25

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.CIR.0000057810.48709.F6PMID 12654604
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• C‐reactive protein as a predictor of improvement and readmission in heart failure

  2002cited by this paper
• Increased gene expression of tumor necrosis factor superfamily ligands in peripheral blood mononuclear cells during chronic heart failure.

  2002cited by this paper
• TNF-α and myocardial matrix metalloproteinases in heart failure: relationship to LV remodeling

  2002cited by this paper
• TNF-alpha and myocardial matrix metalloproteinases in heart failure: relationship to LV remodeling.

  2002cited by this paper
• Prognostic significance of peripheral monocytosis after reperfused acute myocardial infarction:a possible role for left ventricular remodeling.

  2002cited by this paper
• Endothelin Antagonism and Interleukin-6 Inhibition Attenuate the Proatherogenic Effects of C-Reactive Protein

  2002cited by this paper
• Excess mortality of type A aortic dissection in women: impact of delayed diagnosis

  2002cited by this paper
• Do cytokines enable risk stratification to be improved in NYHA functional class III patients? Comparison with other potential predictors of prognosis.

  2002cited by this paper
• Improved post-myocardial infarction survival with probucol in rats: effects on left ventricular function, morphology, cardiac oxidative stress and cytokine expression.

  2002cited by this paper
• Interleukin-6 and viral myocarditis: the Yin-Yang of cardiac innate immune responses.

  2001cited by this paper
• The Role of Interleukin-6 in the Failing Heart

  2001cited by this paper
• C-reactive protein is a strong but nonspecific risk factor of fatal stroke in elderly persons.

  2001cited by this paper
• Elevated interleukin-6 levels in patients with asymptomatic left ventricular systolic dysfunction.

  2001cited by this paper
• C-reactive protein, cardiovascular risk factors, and mortality in a prospective study in the elderly.

  2000cited by this paper
• Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men.

  2000cited by this paper
• Cytokines as emerging targets in the treatment of heart failure.

  2000cited by this paper
• High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure.

  2000cited by this paper
• Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction.

  2000cited by this paper
• Cytokines and adhesion molecules in the course of acute myocardial infarction.

  1999cited by this paper
• Elevated tumor necrosis factor alpha of blood mononuclear cells in patients with congestive heart failure.

  1999cited by this paper
• Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.

  1999cited by this paper
• Monocyte activation in congestive heart failure due to coronary artery disease and idiopathic dilated cardiomyopathy.

  1998cited by this paper
• Septic arthritis with Listeria monocytogenes during low‐dose methotrexate

  1998cited by this paper
• Pathophysiologically relevant concentrations of tumor necrosis factor-alpha promote progressive left ventricular dysfunction and remodeling in rats.

  1998cited by this paper
• Factor-Cardiac Failure in Transgenic Mice With Myocardial Expression of Tumor Necrosis

  1998cited by this paper
• Monocyte cytokine production in an elderly population: effect of age and inflammation.

  1998cited by this paper
• The activated immune system in congestive heart failure – from dropsy to the cytokine paradigm

  1998cited by this paper
• Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-alpha.

  1998cited by this paper
• Cardiac Failure in Transgenic Mice With Myocardial Expression of Tumor Necrosis Factor-α

  1998cited by this paper
• Classification of heart failure in population based research: An assessment of six heart failure scores

  1997cited by this paper
• Increased Expression of Interleukin-1β and Monocyte Chemotactic and Activating Factor/Monocyte Chemoattractant Protein-1 in the Hypertrophied and Failing Heart With Pressure Overload

  1997cited by this paper
• Circulating interleukin-6 in severe heart failure.

  1997cited by this paper
• Cytokines and cardiac contractile function.

  1997cited by this paper
• Increased expression of interleukin-1 beta and monocyte chemotactic and activating factor/monocyte chemoattractant protein-1 in the hypertrophied and failing heart with pressure overload.

  1997cited by this paper
• Circulating levels of cytokines and their endogenous modulators in patients with mild to severe congestive heart failure due to coronary artery disease or hypertension.

  1996cited by this paper
• Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD).

  1996cited by this paper
• Circulating concentrations of proinflammatory cytokines in mild or moderate heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.

  1996cited by this paper
• Continuous activation of gp130, a signal-transducing receptor component for interleukin 6-related cytokines, causes myocardial hypertrophy in mice.

  1995cited by this paper
• Elevated circulating levels of tumor necrosis factor in severe chronic heart failure.

  1990cited by this paper
• Ultrafiltration to remove endotoxins and other cytokine-inducing materials from tissue culture media and parenteral fluids.

  1990cited by this paper
• The natural history of congestive heart failure: the Framingham study.

  1971cited by this paper
• DISEASE OF THE HEART IN THE WORKS OF HIPPOCRATES

  1962cited by this paper
• Epidemiological approaches to heart disease: the Framingham Study.

  1951cited by this paper

• The “Reducing Inflammation for Greater Health Trial (RIGHT)” Study—Concept, Rationale, and Design

  2026cites this paper
• The Potential Role of Anti-Inflammatory Therapy in Heart Failure Treatment.

  2026cites this paper
• Metabolic Stress and Immune Activation in Heart Failure With a Preserved Ejection Fraction

  2026cites this paper
• Inflammation and risk of cardiovascular outcomes in atrial fibrillation and flutter patients: A Nationwide Registry Study.

  2025cites this paper
• The high-sensitivity C-reactive protein to lymphocyte ratio is associated with all-cause and cardiovascular mortality in U.S. adults: A cohort study from NHANES 2015 to 2018

  2025cites this paper
• IL‐6 in the spotlight: From cardiovascular pathophysiology to therapy

  2025cites this paper
• Circulating oxylipins predict mortality in heart failure with preserved ejection fraction

  2025cites this paper
• Multiorgan Dysfunction and its Association With Congestion and Outcome in Aortic Stenosis Treated With TAVI

  2025cites this paper
• Prognostic impact of rheumatic diseases in patients with heart failure with mildly reduced ejection fraction.

  2025cites this paper
• Physiologic Phenotyping of Responses to Exercise and Activity in Heart Failure.

  2025cites this paper
• Predictive Value of Neutrophil-to-lymphocyte Ratio, Platelet-to-lymphocyte Ratio, and Neutrophil-to-lymphocyte ratio and Platelet-to-lymphocyte Ratio Product in Heart Failure: A Cross-sectional Study

  2025cites this paper
• Persistent inflammatory cytokine signature in long Covid-19 patients: a meta-analysis

  2025cites this paper
• Association of Systemic Thromboxane Generation With Risk of Developing Heart Failure.

  2025cites this paper
• Association between oxidative balance score and congestive heart failure in hypertensive patients: NHANES 2009–2018

  2025cites this paper
• Prognostic Value of Pericoronary Fat Attenuation Index on Computed Tomography for Hospitalization for Heart Failure

  2025cites this paper
• Systemic inflammatory regulators and heart failure: A bidirectional 2-sample Mendelian randomization study

  2025cites this paper
• Relationship between the HDL-C/CRP ratio and all-cause mortality in patients with chronic heart failure: a retrospective analysis from Yunnan Province, China

  2025cites this paper
• Risk and temporal trends of heart failure subtypes in rheumatoid arthritis.

  2025cites this paper
• Association Between F‐SIRI and Adverse Prognosis in Patients With Chronic Heart Failure

  2025cites this paper
• Prognostic Value of Modified Glasgow Prognostic Score in Acute Decompensated Heart Failure with Reduced Ejection Fraction

  2025cites this paper
• Multiorgan characterization of inflammasome component expression in a rat model of advanced heart failure

  2025cites this paper
• The Microbiome Connection: A Common Pathway Linking Cancer and Heart Failure

  2025cites this paper
• Deep phenotyping of a modified diabetic cardiomyopathy mouse model which reflects clinical disease progression

  2025cites this paper
• Association of TNF-R1 with Exercise Capacity in Asymptomatic Hypertensive Heart Disease—Mediating Role of Left Ventricular Diastolic Function Deterioration

  2025cites this paper
• Prognostic impact of C-reactive protein in elderly patients with acute heart failure and preserved ejection fraction: the modulating role of carbohydrate antigen 125

  2025cites this paper
• Inflammatory Biomarkers in Heart Failure: Clinical Perspectives on hsCRP, IL-6 and Emerging Candidates

  2025cites this paper
• Applicability of the Framingham Risk Score in predicting mortality among kidney failure patients: an international analysis

  2025cites this paper
• RNA Therapeutics in Heart Failure

  2025cites this paper
• Longitudinal associations between fast food outlet count and inflammatory markers in the US-based nurses' health study II between 1998 and 2011.

  2025cites this paper
• The role of sex differences in cardiovascular, metabolic, and immune functions in health and disease: a review for “Sex Differences in Health Awareness Day”

  2025cites this paper
• A Comprehensive Review: Unraveling the Role of Inflammation in the Etiology of Heart Failure

  2025cites this paper
• Contributions of Inflammation to Cardiometabolic Heart Failure with Preserved Ejection Fraction.

  2024cites this paper
• Sleep disturbances and heart failure: observational study and Mendelian randomization study

  2024cites this paper
• Hyperuricemia Is Associated With Higher Mortality in Non-diabetic Heart Failure Patients

  2024cites this paper
• Cardio-rheumatology: present and future. Part I

  2024cites this paper
• Causal effect of interleukin (IL)-6 on blood pressure and hypertension: A mendelian randomization study

  2024cites this paper
• Beyond Natriuretic Peptides: Unveiling the Power of Emerging Biomarkers in Heart Failure

  2024cites this paper
• Evolving mechanisms and presentations of cardiovascular disease in people with HIV: implications for management

  2024cites this paper
• IL‐6 and hsCRP predict cardiovascular mortality in patients with heart failure with preserved ejection fraction

  2024cites this paper
• The therapeutic effect of NRF2 activator, ezetimibe, in cardiac cachexia

  2024influential citation
• Dapagliflozin, inflammation and left ventricular remodelling in patients with type 2 diabetes and left ventricular hypertrophy

  2024cites this paper
• Does Serum Uric Acid to Creatinine Ratio Predict Mortality Risk in Patients With Heart Failure?

  2024cites this paper
• Challenging and target-based shifting strategies for heart failure treatment: An update from the last decades.

  2024cites this paper
• Prognostic value of lymphocyte to C-reactive protein ratio for cardiovascular and all-cause mortality in adults with congestive heart failure in the United States: NHANES 1999–2010

  2024cites this paper
• Letter: Modified Glasgow Prognostic Score as a New Biomarker for the Prognosis of Acute Coronary Syndrome Patients

  2024cites this paper
• Higher C-Reactive Protein to Albumin Ratio Portends Long-Term Mortality in Patients with Chronic Heart Failure and Reduced Ejection Fraction

  2024cites this paper
• The combination of high uric acid and high C-reactive protein increased the risk of cardiovascular disease: A 15-year prospective cohort study.

  2024cites this paper
• Assessment of the Relationship between Periodontitis and Cardiac Parameters in Patients with Early Chronic Heart Failure: A Cross-Sectional Study

  2024cites this paper
• Inflammation in heart failure: pathophysiology and therapeutic strategies

  2024cites this paper
• Clinical prognostic impact of C-NLR in heart failure patients with different ejection fractions: a retrospective study

  2024influential citation
• Characteristics, Treatment, and Prognosis of Heart Failure Patients with Chronic Obstructive Pulmonary Disease in the Colombian Heart Failure Registry (RECOLFACA)

  2024cites this paper
• Combination of Deferoxamine With Cyclosporine Synergistically Blunt Renal Cold Ischemia-Reperfusion Injury in Rat Transplantation Model.

  2024cites this paper
• Inflammation and Heart Failure: Searching for the Enemy—Reaching the Entelechy

  2023cites this paper
• Advances in congestive heart failure biomarkers.

  2023cites this paper
• Autoantibodies against the chemokine receptor 3 predict cardiovascular risk

  2023cites this paper
• Relationship between brain structural network integrity and emotional symptoms in youth with perinatally-acquired HIV.

  2023cites this paper
• Eicosanoid and eicosanoid-related inflammatory mediators and exercise intolerance in heart failure with preserved ejection fraction

  2023cites this paper
• Inflammation, dysregulated iron metabolism, and cardiovascular disease

  2023cites this paper
• C-Reactive Protein and Risk of Incident Heart Failure in Patients With Cardiovascular Disease.

  2023cites this paper
• Do Interleukin-1 and Interleukin-6 Antagonists Hold Any Place in the Treatment of Atherosclerotic Cardiovascular Disease and Related Co-Morbidities? An Overview of Available Clinical Evidence

  2023cites this paper
• A Literature Review on the Coexisting Chronic Obstructive Pulmonary Disease and Heart Failure

  2023cites this paper
• lncRNA TUG1 as potential novel biomarker for prognosis of cardiovascular diseases.

  2023cites this paper
• Serum apolipoprotein B to apolipoprotein A‐I ratio predicts mortality in patients with heart failure

  2023cites this paper
• Emerging Roles for Dendritic Cells in Heart Failure

  2023cites this paper
• Cardiovascular Disease Burden and Major Adverse Cardiac Events in Young Black Patients: A National Analysis of 2 Cohorts 10 Years Apart (2017 Versus 2007)

  2023cites this paper
• Association between serum albumin to serum creatinine ratio and mortality risk in patients with heart failure

  2023cites this paper
• Predictive Value of the Prognostic Nutritional Index for Long-Term Mortality in Patients with Advanced Heart Failure.

  2023cites this paper
• INTERLEUKIN-6 – MARKER OF SUBCLINICAL INFLAMMATION IN VERY ELDERLY PATIENTS AND CENTENARIANS WITH CORONARY ARTERY DISEASE

  2023cites this paper
• Inflammation biomarkers are associated with the incidence of cardiovascular disease: a meta-analysis

  2023cites this paper
• Predictive value of Serum CCL21 and CCL19 levels in heart failure patients: A prospective study

  2023cites this paper
• Causal effects of circulating vitamin levels on the risk of heart failure: a Mendelian randomization study.

  2023cites this paper
• Early diagnosis of subclinical left ventricular dysfunction in postmenopausal women with rheumatoid arthritis

  2023cites this paper
• Inflammatory Mechanisms in Heart Failure with Preserved Ejection Fraction.

  2023cites this paper
• Effect of C-reactive protein on the risk of Heart failure: a mendelian randomization study

  2023cites this paper
• Non-coding RNA mediates endoplasmic reticulum stress-induced apoptosis in heart disease

  2023cites this paper
• The Framingham Study on Cardiovascular Disease Risk and Stress-Defenses: A Historical Review

  2023cites this paper
• Association of Interleukin-6 and Interleukin-18 with Cardiovascular Disease in Older Adults: Atherosclerosis Risk in Communities Study.

  2023cites this paper
• Locomotor and respiratory muscle abnormalities in HFrEF and HFpEF

  2023cites this paper
• Diagnostic and prognostic biomarkers reflective of cardiac remodelling in diabetes mellitus: A scoping review

  2023cites this paper
• C-reactive protein and statins in heart failure with reduced and preserved ejection fraction

  2022cites this paper
• Potential Biological Mediators of Myocardial and Vascular Complications of Air Pollution-A State-of-the-Art Review.

  2022cites this paper
• Association of immune cell subsets with incident heart failure in two population‐based cohorts

  2022cites this paper
• Sex-dependent mechanisms of cell death modalities in cardiovascular disease.

  2022cites this paper
• Inflammation and heart failure: a two-sample Mendelian randomization study

  2022cites this paper
• The hormetic and hermetic role of IL-6.

  2022cites this paper
• Candidate Plasma Biomarkers to Detect Anthracycline‐Related Cardiomyopathy in Childhood Cancer Survivors: A Case Control Study in the Dutch Childhood Cancer Survivor Study

  2022cites this paper
• A novel identified circular RNA, circSnap47, promotes heart failure progression via regulation of miR-223-3p/MAPK axis

  2022cites this paper
• Associations of empirical dietary inflammatory index with heart failure in adults from the United States

  2022cites this paper
• Periodontal Status, C-Reactive Protein, NT-proBNP, and Incident Heart Failure: The ARIC Study.

  2022cites this paper
• Recent Advances in Anxiety Disorders and Cardiovascular Diseases

  2022cites this paper
• Effects of mango and mint pod-based e-cigarette aerosol inhalation on inflammatory states of the brain, lung, heart, and colon in mice

  2022cites this paper
• Cardiovascular Biomarkers: Lessons of the Past and Prospects for the Future

  2022cites this paper
• Multi-system trajectories and the incidence of heart failure in the Framingham Offspring Study

  2022cites this paper
• FCGR2A-HH Gene Variants Encoding the Fc Gamma Receptor for the C-Reactive Protein Are Associated with Enhanced Monocyte CD32 Expression and Cardiovascular Events’ Recurrence after Primary Acute Coronary Syndrome

  2022cites this paper
• Highly Sensitive C Reactive Protein as a Predictor of in Hospital Outcome in Patients with Acute Coronary Syndrome

  2022cites this paper
• HDL Composition, Heart Failure, and Its Comorbidities

  2022cites this paper
• Influence of Cytokines on Inflammatory Eye Diseases: A Citation Network Study

  2022cites this paper
• Kynurenine Pathway Metabolites as Potential Clinical Biomarkers in Coronary Artery Disease

  2022cites this paper
• Fibronectin type III domain‐containing 5 improves aging‐related cardiac dysfunction in mice

  2022cites this paper
• Current landscape of preclinical models of diabetic cardiomyopathy.

  2022cites this paper